skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Like many here I suspect, we missed the cannabis event completely. Fearing to be too late, trying to ascertain whether to enter via an ETF like HMMJ (the only one I can find with any kind of liquidity) or do I try to build a small "equal weight" holding of the 5 or 6 stronger entities in this space. So how would you rank today the top 5 or 6 entities trying to build a presence or should one try to follow on the coat tails of an established company trying to enter the cannabis space like ATD.b or one of the liquor companies?
Read Answer Asked by William Ross on March 07, 2019
Q: You provided me with 17 names in my previous question I assume this is for diversification, I will likely purchase equals amounts of each and save some for a couple of speculative to keep it interesting. What would your top three speculative (potential home run) stocks be today?
Read Answer Asked by Lorne on March 05, 2019
Q: CJT: I have an unrealized gain of 996%, yes, 996%. I bought it at $7.70 and it's currently at $84.40. Most of your comments are positive about this company, except regarding the debt level. Do you see any issues or concerns to continue holding this stock for years to come? In a case like this massive gain, it is better to take at least some profits?
Read Answer Asked by Helen on March 05, 2019
Q: I've done very well holding Cargojet for the last 5 years. However, I just read the CFRA, QUANTITATIVE STOCK REPORT dated March 01, 2019. and it rates this stock as a SELL. Further, the report states: " TSX: CJT's SELL recommendation is based on its score from CFRA's quantitative model for Canada." Is there any cause for concern? Is this due to their debt load?
Read Answer Asked by Helen on March 04, 2019
Q: What do you think of JWEL's latest Fourth Quarter and full year 2018 results - would you buy at these levels. I bought it when it first went public - like the China exposure and the recent partnership with atop pharmacy chain in India - also their quality control is known for being very high as well - was thinking of adding more at these prices.
Read Answer Asked by Karen on February 28, 2019
Q: I've done very well with SHOP (thanks to 5i) but it has grown to 12% of my overall portfolio. I really like to let the winners run, and am quite risk tolerant, however I am considering selling 20% and reinvesting the proceeds. I plan to top up KXS, which seems has good momentum, but need some other suggestions. What other technology stocks would you suggest at this time? Options outside of tech would be appreciated too.
Read Answer Asked by David on February 26, 2019
Q: Hello Peter,
I like your response from the previous question on Canntrust but I would appreciate it if you can provide comments as to why this company which has been touted by analysts and BNN guests as one of the better players in the cannibis space, yet it has performed poorly when compared to most of the mid and large cap players. When you look at the chart from inception to now, Canntrust has not done well. Their fundamentals and strategy appear to be sound but why such a gap (comparing to weed, acb, cron, hexo, ogi, etc).
Also, on another note, KSHB, Kush holdings is bascially a picks and shovels play in the US for cannibis packaging etc and only trades over the counter (not on your list). It plans to list on nasdaq or nyse. If this happens, what would happen to my shares if they were bought over the counter. Would i be able to sell same shares on nyse or nasdaq. Apppreciate it.
Read Answer Asked by umedali on February 25, 2019